La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Pro-Dex Résultats passés
Passé contrôle des critères 1/6
Pro-Dex has been growing earnings at an average annual rate of 0.8%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 12% per year. Pro-Dex's return on equity is 6.6%, and it has net margins of 4.1%.
Informations clés
0.8%
Taux de croissance des bénéfices
3.8%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 8.9% |
| Taux de croissance des recettes | 12.0% |
| Rendement des fonds propres | 6.6% |
| Marge nette | 4.1% |
| Dernière mise à jour des bénéfices | 31 Mar 2024 |
Mises à jour récentes des performances passées
Recent updates
The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence
Jul 18
Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality
Feb 16Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly
Feb 14Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jan 24Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet
May 20Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital
Oct 05Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting
Sep 26When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?
Sep 20Pro-Dex GAAP EPS of $0.38, revenue of $12.61M
Aug 25Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?
May 10Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?
Apr 21Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price
Mar 14Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?
Feb 09We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt
Nov 17Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?
Aug 29A History Of Strong Growth Rates: Pro-Dex On Sale
Aug 25The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising
May 18What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?
Mar 29Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 15The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted
Feb 26Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)
Feb 13
We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)
Feb 08Pro-Dex EPS misses by $0.27, misses on revenue
Feb 04Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?
Jan 25What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?
Jan 11How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?
Dec 28With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting
Dec 14What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?
Nov 30Ventilation des recettes et des dépenses
Comment Pro-Dex gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 24 | 49 | 2 | 5 | 2 |
| 31 Dec 23 | 48 | 3 | 5 | 2 |
| 30 Sep 23 | 47 | 5 | 5 | 2 |
| 30 Jun 23 | 46 | 7 | 5 | 2 |
| 31 Mar 23 | 48 | 8 | 5 | 2 |
| 31 Dec 22 | 44 | 7 | 5 | 2 |
| 30 Sep 22 | 43 | 5 | 6 | 2 |
| 30 Jun 22 | 42 | 5 | 6 | 2 |
| 31 Mar 22 | 39 | 3 | 5 | 3 |
| 31 Dec 21 | 41 | 5 | 6 | 3 |
| 30 Sep 21 | 39 | 6 | 6 | 4 |
| 30 Jun 21 | 38 | 6 | 5 | 4 |
| 31 Mar 21 | 40 | 8 | 5 | 3 |
| 31 Dec 20 | 36 | 7 | 5 | 3 |
| 30 Sep 20 | 36 | 6 | 4 | 2 |
| 30 Jun 20 | 35 | 6 | 4 | 2 |
| 31 Mar 20 | 31 | 4 | 3 | 2 |
| 31 Dec 19 | 29 | 4 | 3 | 2 |
| 30 Sep 19 | 27 | 4 | 3 | 2 |
| 30 Jun 19 | 27 | 4 | 3 | 2 |
| 31 Mar 19 | 26 | 3 | 3 | 2 |
| 31 Dec 18 | 25 | 3 | 3 | 2 |
| 30 Sep 18 | 24 | 2 | 3 | 2 |
| 30 Jun 18 | 22 | 2 | 3 | 2 |
| 31 Mar 18 | 22 | 2 | 3 | 2 |
| 31 Dec 17 | 23 | 2 | 3 | 2 |
| 30 Sep 17 | 22 | 5 | 3 | 1 |
| 30 Jun 17 | 22 | 5 | 3 | 1 |
| 31 Mar 17 | 21 | 4 | 3 | 1 |
| 31 Dec 16 | 20 | 4 | 3 | 1 |
| 30 Sep 16 | 20 | 2 | 3 | 1 |
| 30 Jun 16 | 19 | 1 | 3 | 1 |
| 31 Mar 16 | 18 | 1 | 3 | 1 |
| 31 Dec 15 | 17 | 0 | 3 | 1 |
| 30 Sep 15 | 15 | 0 | 3 | 2 |
| 30 Jun 15 | 13 | 0 | 3 | 2 |
| 31 Mar 15 | 13 | 0 | 3 | 2 |
| 31 Dec 14 | 11 | -1 | 2 | 2 |
| 30 Sep 14 | 11 | -1 | 2 | 1 |
| 30 Jun 14 | 11 | -1 | 2 | 1 |
| 31 Mar 14 | 10 | -1 | 3 | 2 |
| 31 Dec 13 | 11 | -2 | 3 | 2 |
| 30 Sep 13 | 11 | -2 | 3 | 2 |
Des revenus de qualité: PDEX has a large one-off loss of $3.3M impacting its last 12 months of financial results to 31st March, 2024.
Augmentation de la marge bénéficiaire: PDEX's current net profit margins (4.1%) are lower than last year (16%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: PDEX's earnings have grown by 0.8% per year over the past 5 years.
Accélération de la croissance: PDEX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: PDEX had negative earnings growth (-73.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (5.5%).
Rendement des fonds propres
ROE élevé: PDEX's Return on Equity (6.6%) is considered low.